ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Retail Trade

Welcia Holdings Co., Ltd.

In the news

Business Summary

Welcia Holdings Co., Ltd. engages in the management of its subsidiaries and group companies which are in the pharmaceutical business. Its core business deals with the operation of drug store chains which offer prescription drugs and pharmaceuticals, sanitation and nursing care items, health food products, baby supplies, cosmetics, and household sundries. The company was founded on September 1, 2008 and is headquartered in Tokyo, Japan.

Financial Highlights

Feb 2020 JPYUSD
Revenue868,280M7,965.15M
Gross Profit252,061M2,312.27M
Operating income37,803M346.78M
Income before tax35,936M329.65M
Net income22,802M209.17M
EBITDA53,466M490.46M
Diluted EPS109.121.00
Dividends Per Share250.22
Total Assets390,006M3,615.68M
Total liabilities227,584M2,109.89M
Total equity161,925M1,501.18M
Operating cash flow70,156M643.57M
Currency in JPYCurrency in USD

Historical Data

JPY | USD
 Feb 2016Feb 2017Feb 2018Feb 2019Feb 2020
Revenue 528,402M 623,163M 695,268M 779,148M 868,280M
Gross Profit 139,902M 172,155M 196,958M 222,431M 252,061M
Operating income 18,759M 24,080M 28,827M 29,046M 37,803M
Income before tax 16,511M 23,184M 26,777M 28,511M 35,936M
Net income 9,527M 14,450M 17,165M 17,423M 22,802M
EBITDA 29,042M 36,033M 42,093M 43,542M 53,466M
Diluted EPS 48.81 69.39 82.38 83.53 109.12
Dividends Per Share 10.50 14.25 18.50 21 25
Total Assets 228,227M 248,883M 292,238M 327,426M 390,006M
Total liabilities 124,448M 132,648M 161,751M 183,474M 227,584M
Total equity 103,771M 116,227M 129,732M 143,287M 161,925M
Operating cash flow 15,031M 33,303M 35,902M 34,872M 70,156M
 Feb 2016Feb 2017Feb 2018Feb 2019Feb 2020
Revenue 4,376.83M 5,755.66M 6,240.85M 7,052.42M 7,965.15M
Gross Profit 1,158.83M 1,590.06M 1,767.93M 2,013.32M 2,312.27M
Operating income 155.38M 222.40M 258.75M 262.90M 346.78M
Income before tax 136.76M 214.13M 240.35M 258.06M 329.65M
Net income 78.91M 133.46M 154.07M 157.70M 209.17M
EBITDA 240.55M 332.80M 377.83M 394.11M 490.46M
Diluted EPS 0.40 0.64 0.73 0.75 1.00
Dividends Per Share 0.08 0.13 0.16 0.19 0.22
Total Assets 2,021.94M 2,224.45M 2,738.74M 2,941.30M 3,615.68M
Total liabilities 1,102.52M 1,185.57M 1,515.87M 1,648.16M 2,109.89M
Total equity 919.34M 1,038.80M 1,215.80M 1,287.16M 1,501.18M
Operating cash flow 124.50M 307.59M 322.26M 315.64M 643.57M

Valuation Measures

Feb 2020
PER29.75
ROA6.35%
ROE14.94%
Operating margin4.35%
Profit margin2.62%

Key executives

  • President, COO & Representative Director: Tadahisa Matsumoto
  • Chief Financial Officer & Senior Managing Director: Norimasa Sato
  • Director & Executive Officer: Takashi Abe
  • MD, Head-Public Relations, Legal, Operations & IR: Juichi Nakamura
  • Auditor: Toshio Miyamoto

Shareholders

  • AEON Co., Ltd. (50.5%)
  • Asset Management One Co., Ltd. (3.5%)
  • Fidelity Management & Research Co. LLC (1.8%)
  • Nomura Asset Management Co., Ltd. (1.7%)
  • TSURUHA Holdings, Inc. (1.5%)
  • Welcia Holdings Employee Stockownership Plan (1.5%)
  • BlackRock Fund Advisors (1.3%)
  • The Vanguard Group, Inc. (1.2%)
  • Daiwa Asset Management Co. Ltd. (0.8%)
  • Nikko Asset Management Co., Ltd. (0.8%)

Contact Details

  • Website:http://www.welcia.co.jp
  • Address: Welcia Building, 2-2-15 Sotokanda, Tokyo, 101-0021, Japan
  • Phone: +81.3.5207.5878

Related Companies

  • Summit KK
  • Neo Pharma, Inc.
  • Kusuri No Marue KK
  • Masaya KK
  • IPPONDO Co., Ltd.
  • Welcia Holdings Board Incentive Plan
  • Welcia Holdings Employee Incentive Plan 2
  • Welcia Holdings Employee Incentive Plan 1
  • Lianhua Meiriling Commercial (Shanghai) Co., Ltd.
  • Nagata Yakkyoku KK
  • Kanamitsu Yakuhin KK
  • Yodoya KK
  • Marudai Sakurai Pharmacy Ltd.
  • Takiya Co., Ltd.
  • Welcia Holdings Employee Stockownership Plan
  • Shimizu Drug KK
  • Welcia Yakkyoku Co., Ltd.

Competitors

  • TSURUHA Holdings, Inc.
  • KUSURI NO AOKI HOLDINGS CO.,LTD.
  • Sundrug Co., Ltd.
  • SATUDORA HOLDINGS CO., LTD.
  • cocokara fine Inc.

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Last Updated on 25 Jan, 2021

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close